Selenomethionine suppresses head and neck squamous cell carcinoma progression through TopBP1/ATR and TCAB1 signaling
CONCLUSION: Our findings show that SeMet inhibits the proliferation of HNSCC cells and promotes their apoptosis by targeting TopBP1/ATR and TCAB1 signaling. SeMet is a potential method for HNSCC treatment.PMID:37750664 | DOI:10.14670/HH-18-665 (Source: Histology and Histopathology)
Source: Histology and Histopathology - September 26, 2023 Category: Cytology Authors: Bo Zhang Xiaodong Wei Jiwu Li Source Type: research